famotidine has been researched along with Gastritis in 27 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate the effect of famotidine, a histamine receptor antagonist on corpus gastritis in patients with peptic ulcer disease." | 9.11 | Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease. ( Chayama, K; Haruma, K; Hata, J; Ito, M; Kamada, T; Kawamura, Y; Kusunoki, H; Sugiu, K; Tanaka, S, 2005) |
| " The present work aimed to annotate the secondary metabolites from a butanol fraction of apple leaves (BLE), evaluate the gastro-protective and healing effects of this fraction against indomethacin-induced gastric ulcers in rats and to identify its mechanism of action." | 8.31 | Apple (Malus domestica Borkh) leaves attenuate indomethacin-induced gastric ulcer in rats. ( Abdelfattah, MAO; Abdo, W; Drissi, B; El-Shazly, AM; Mahmoud, MF; Nabil, M; Sobeh, M, 2023) |
| "In this multicenter prospective single-arm open-label study, 10,311 patients with a clinical diagnosis of chronic symptomatic gastritis were enrolled and each patient was administered famotidine at 20 mg/day for 4 weeks." | 7.78 | Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study. ( Chiba, T; Kinoshita, Y, 2012) |
| "In order to evaluate the symptomatic efficacy of cisapride on motility disorders often associated with mild inflammatory changes of the upper gastrointestinal tract, the authors carried out a comparison between two groups of patients (15 patients in each group, 10 males and 5 females) with histologic antral gastritis, treated respectively with famotidine 40 mg/day per os plus cisapride 10 mg ter/die per os, and famotidine alone." | 7.69 | [Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis]. ( Dallera, F; Gendarini, A; Scanzi, G, 1994) |
| "7% of the patients in the 10- and 20-mg dosage groups, respectively, did not have evidence of erosions or hemorrhages, compared with 73% of patients in the 5-mg group." | 6.66 | Famotidine in the treatment of gastritis. ( Miwa, T; Miyoshi, A, 1987) |
| "Omeprazole was more effective than famotidine in keeping gastric pH high and lowering the total gastric acid output." | 5.32 | Omeprazole is more effective than famotidine for preventing acute gastritis in rats. ( Akturk, Z; Ekinci, H; Muftuoglu, T; Peker, O; Topaloglu, U; Unalmiser, S, 2004) |
| "When lafutidine (3, 10 mg/kg) was administered orally once daily for one week after the withdrawal of ammonia or TCA solution, the recovery of the mucosal thickness in the fundic gland area and the parietal cell number were significantly accelerated, and the recovery of mucosal thickness in the pyloric gland area also tended to be accelerated." | 5.30 | [Effect of a novel antiulcer drug, lafutidine, on experimental chronic gastritis in rats]. ( Inaba, N; Onodera, S; Shibata, M; Suzuki, T; Tanaka, M; Yamaura, T, 1997) |
| "To characterize and compare acid suppression (pharmacodynamics) and pharmacokinetics of IV famotidine and ranitidine in critically ill children at risk for stress gastritis." | 5.19 | Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children. ( Kauffman, R; Lai, ML; Lehr, VT; Madani, S; Sarniak, A; Simpson, P; Tolia, V, 2014) |
| "The aim of this study was to evaluate the effect of famotidine, a histamine receptor antagonist on corpus gastritis in patients with peptic ulcer disease." | 5.11 | Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease. ( Chayama, K; Haruma, K; Hata, J; Ito, M; Kamada, T; Kawamura, Y; Kusunoki, H; Sugiu, K; Tanaka, S, 2005) |
| " pylori-positive patients who had peptic ulcers or reflux oesophagitis were treated for 3 years with either omeprazole (20 mg/day) alone (n=7) or with omeprazole for primary therapy (8 weeks), followed by famotidine (40 mg/day) for maintenance therapy (n=134)." | 5.09 | Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan. ( Mashiba, H; Matsumura, N; Okamoto, S; Sasaki, N; Taniyama, K; Uemura, N; Yamaguchi, S; Yamamoto, S, 2000) |
| " The present work aimed to annotate the secondary metabolites from a butanol fraction of apple leaves (BLE), evaluate the gastro-protective and healing effects of this fraction against indomethacin-induced gastric ulcers in rats and to identify its mechanism of action." | 4.31 | Apple (Malus domestica Borkh) leaves attenuate indomethacin-induced gastric ulcer in rats. ( Abdelfattah, MAO; Abdo, W; Drissi, B; El-Shazly, AM; Mahmoud, MF; Nabil, M; Sobeh, M, 2023) |
| "In this multicenter prospective single-arm open-label study, 10,311 patients with a clinical diagnosis of chronic symptomatic gastritis were enrolled and each patient was administered famotidine at 20 mg/day for 4 weeks." | 3.78 | Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study. ( Chiba, T; Kinoshita, Y, 2012) |
| " pylori-infected patients with duodenal ulcer were treated with either omeprazole or famotidine plus two antibiotics for 2 wk." | 3.70 | The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. ( Acevedo, C; Duarte, I; Figueroa, C; Fuster, F; Giancaspero, R; Hola, K; Rollan, A; Schulz, M, 2000) |
| "In order to evaluate the symptomatic efficacy of cisapride on motility disorders often associated with mild inflammatory changes of the upper gastrointestinal tract, the authors carried out a comparison between two groups of patients (15 patients in each group, 10 males and 5 females) with histologic antral gastritis, treated respectively with famotidine 40 mg/day per os plus cisapride 10 mg ter/die per os, and famotidine alone." | 3.69 | [Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis]. ( Dallera, F; Gendarini, A; Scanzi, G, 1994) |
| " Therefore, the possible reverting properties of H2RA (cimetidine, ranitidine, and famotidine) were tested in ethanol-induced gastritis." | 3.69 | Reversion by histamine H2-receptor antagonists of plasma membrane alterations in ethanol-induced gastritis. ( Hernández-Muñoz, R; Montiel-Ruíz, F, 1996) |
| "48 patients in whom previous endoscopic signs of chronic gastritis had been abolished by treatment with either 1 g sucralfate three times daily or 40 mg famotidine at night were followed up for 3 months without further therapy." | 3.68 | Follow-up of endoscopic gastritis after healing with sucralfate or an H2-receptor antagonist. ( Ballarin, E; Fanti, L; Guslandi, M; Sorghi, M; Tittobello, A, 1992) |
| "The effect of ranitidine 300 mg po given at 1800 h (famotidine 40 mg/cimetidine 800 mg) on the night time gastric pH was tested using longterm intragastric pH monitoring in 27 patients with and 32 patients without liver cirrhosis." | 3.67 | Frequent non-response to histamine H2-receptor antagonists in cirrhotics. ( Bode, JC; Klotz, U; Krishna, DR; Walker, S, 1989) |
| "7% of the patients in the 10- and 20-mg dosage groups, respectively, did not have evidence of erosions or hemorrhages, compared with 73% of patients in the 5-mg group." | 2.66 | Famotidine in the treatment of gastritis. ( Miwa, T; Miyoshi, A, 1987) |
| "Omeprazole was more effective than famotidine in keeping gastric pH high and lowering the total gastric acid output." | 1.32 | Omeprazole is more effective than famotidine for preventing acute gastritis in rats. ( Akturk, Z; Ekinci, H; Muftuoglu, T; Peker, O; Topaloglu, U; Unalmiser, S, 2004) |
| "When lafutidine (3, 10 mg/kg) was administered orally once daily for one week after the withdrawal of ammonia or TCA solution, the recovery of the mucosal thickness in the fundic gland area and the parietal cell number were significantly accelerated, and the recovery of mucosal thickness in the pyloric gland area also tended to be accelerated." | 1.30 | [Effect of a novel antiulcer drug, lafutidine, on experimental chronic gastritis in rats]. ( Inaba, N; Onodera, S; Shibata, M; Suzuki, T; Tanaka, M; Yamaura, T, 1997) |
| "Treatment with amoxicillin, metronidazole, and famotidine may not be effective in eradicating gastric infections with Helicobacter spp in dogs." | 1.30 | Use of a [13C]urea breath test for detection of gastric infection with Helicobacter spp in dogs. ( Cornetta, AM; Gleed, RD; McDonough, PL; Simpson, KW; Strauss-Ayali, D, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (11.11) | 18.7374 |
| 1990's | 10 (37.04) | 18.2507 |
| 2000's | 10 (37.04) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Mahmoud, MF | 1 |
| Abdo, W | 1 |
| Nabil, M | 1 |
| Drissi, B | 1 |
| El-Shazly, AM | 1 |
| Abdelfattah, MAO | 1 |
| Sobeh, M | 1 |
| Kim, HY | 2 |
| Hwang, JG | 1 |
| Kim, JW | 1 |
| Seong, CH | 1 |
| Lee, JH | 1 |
| Choi, YS | 1 |
| Min, HJ | 1 |
| Kim, HS | 1 |
| Kim, YK | 1 |
| Park, MK | 1 |
| Madani, S | 1 |
| Kauffman, R | 1 |
| Simpson, P | 1 |
| Lehr, VT | 1 |
| Lai, ML | 1 |
| Sarniak, A | 1 |
| Tolia, V | 1 |
| Kinoshita, Y | 1 |
| Chiba, T | 1 |
| Mak, SK | 1 |
| Loo, CK | 1 |
| Wong, AM | 1 |
| Wong, PN | 1 |
| Lo, KY | 1 |
| Tong, GM | 1 |
| Lam, EK | 1 |
| Wong, AK | 1 |
| Graham, DY | 1 |
| Opekun, AR | 1 |
| Jogi, M | 1 |
| Yamaoka, Y | 1 |
| Lu, H | 1 |
| Reddy, R | 1 |
| El-Zimaity, HM | 1 |
| Topaloglu, U | 1 |
| Muftuoglu, T | 1 |
| Akturk, Z | 1 |
| Ekinci, H | 1 |
| Peker, O | 1 |
| Unalmiser, S | 1 |
| Korukov, B | 1 |
| Ognianov, S | 1 |
| Kostadinova, R | 1 |
| Gerzilov, P | 1 |
| Ivanov, A | 1 |
| Iarŭmov, N | 1 |
| Moriyama, T | 1 |
| Matsumoto, T | 1 |
| Jo, Y | 1 |
| Yada, S | 1 |
| Hirahashi, M | 1 |
| Yao, T | 1 |
| Iida, M | 1 |
| Kamada, T | 1 |
| Hata, J | 1 |
| Kusunoki, H | 1 |
| Sugiu, K | 1 |
| Ito, M | 1 |
| Tanaka, S | 1 |
| Kawamura, Y | 1 |
| Chayama, K | 1 |
| Haruma, K | 1 |
| Varughese, GI | 1 |
| Scarpello, JH | 1 |
| Okhlobystin, AV | 1 |
| Gschwantler, M | 1 |
| Weiss, W | 1 |
| Penka, G | 1 |
| Zirm, B | 1 |
| Stupnicki, T | 1 |
| Spath, P | 1 |
| Dallera, F | 1 |
| Scanzi, G | 1 |
| Gendarini, A | 1 |
| Hernández-Muñoz, R | 1 |
| Montiel-Ruíz, F | 1 |
| Onodera, S | 1 |
| Tanaka, M | 1 |
| Inaba, N | 1 |
| Suzuki, T | 1 |
| Shibata, M | 1 |
| Yamaura, T | 1 |
| Malov, IuS | 1 |
| Kulikov, AN | 1 |
| Kato, K | 1 |
| Sasaki, H | 1 |
| Ido, M | 1 |
| Iwata, M | 1 |
| Naganuma, T | 1 |
| Fujimori, K | 1 |
| Cornetta, AM | 1 |
| Simpson, KW | 1 |
| Strauss-Ayali, D | 1 |
| McDonough, PL | 1 |
| Gleed, RD | 1 |
| Rollan, A | 1 |
| Giancaspero, R | 1 |
| Fuster, F | 1 |
| Acevedo, C | 1 |
| Figueroa, C | 1 |
| Hola, K | 1 |
| Schulz, M | 1 |
| Duarte, I | 1 |
| Uemura, N | 1 |
| Okamoto, S | 1 |
| Yamamoto, S | 1 |
| Matsumura, N | 1 |
| Yamaguchi, S | 1 |
| Mashiba, H | 1 |
| Sasaki, N | 1 |
| Taniyama, K | 1 |
| Ivanova, S | 1 |
| Gavrilova, V | 1 |
| Dimitrov, L | 1 |
| Guslandi, M | 1 |
| Ballarin, E | 1 |
| Fanti, L | 1 |
| Sorghi, M | 1 |
| Tittobello, A | 1 |
| Sartori, S | 1 |
| Nielsen, I | 1 |
| Maestri, A | 1 |
| Beltrami, D | 1 |
| Trevisani, L | 1 |
| Pazzi, P | 1 |
| Walker, S | 1 |
| Krishna, DR | 1 |
| Klotz, U | 1 |
| Bode, JC | 1 |
| Miwa, T | 1 |
| Miyoshi, A | 1 |
| Blanco, M | 1 |
| Pajares, JM | 1 |
| Jimenez, ML | 1 |
| Lopez-Brea, M | 1 |
9 trials available for famotidine and Gastritis
| Article | Year |
|---|---|
Comparison of the acid suppression effects between low-dose esomeprazole and famotidine in healthy subjects.
Topics: Cross-Over Studies; Esomeprazole; Famotidine; Gastritis; Healthy Volunteers; Humans | 2023 |
Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
Topics: Child; Child, Preschool; Critical Illness; Famotidine; Female; Gastric Acid; Gastric Acidity Determi | 2014 |
[Study on the efficacy of famotidine (Quamatel) in the complex treatment of erosive gastroduodenitis, stress stomach ulcer and peptic duodenal ulcer].
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Bulgaria; Duodenal Ulcer; Famotidine; Female; Gas | 2004 |
Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Ulcer Agents; Famotidine; Female; Gastric Acid; Gastritis; H | 2005 |
Eradication of Helicobacter pylori by a combination of amoxicillin and famotidine.
Topics: Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Gastritis; Helicobacter | 1995 |
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan.
Topics: Anti-Ulcer Agents; Enzyme Inhibitors; Famotidine; Gastric Mucosa; Gastritis; Gastroscopy; Helicobact | 2000 |
[Intravenous treatment with quamatel in reflux-esophagus and erosive gastritis].
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Esophagitis, Peptic; Famotidine; Female; Gastritis; Gast | 2000 |
Famotidine in the treatment of gastritis.
Topics: Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Famoti | 1987 |
Effect of acid inhibition on Campylobacter pylori.
Topics: Adult; Campylobacter; Campylobacter Infections; Duodenitis; Famotidine; Female; Gastric Acid; Gastri | 1988 |
18 other studies available for famotidine and Gastritis
| Article | Year |
|---|---|
Apple (Malus domestica Borkh) leaves attenuate indomethacin-induced gastric ulcer in rats.
Topics: Animals; Cyclooxygenase 2; Cytokines; Famotidine; Gastric Mucosa; Gastritis; HSP70 Heat-Shock Protei | 2023 |
Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study.
Topics: Adult; Aged; Chronic Disease; Dyspepsia; Famotidine; Female; Gastritis; Heartburn; Histamine H2 Anta | 2012 |
Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combinat | 2002 |
False negative urea breath tests with H2-receptor antagonists: interactions between Helicobacter pylori density and pH.
Topics: Adolescent; Adult; Aged; Biopsy; Breath Tests; Citric Acid; Endoscopy, Gastrointestinal; False Negat | 2004 |
Omeprazole is more effective than famotidine for preventing acute gastritis in rats.
Topics: Animals; Anti-Ulcer Agents; Cell Count; Famotidine; Gastric Acid; Gastric Mucosa; Gastritis; Hydroge | 2004 |
Mucosal proinflammatory cytokine and chemokine expression of gastroduodenal lesions in Crohn's disease.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Case-Control Studies; Chemokines; Crohn Disease; Cytokin | 2005 |
Metformin and vitamin B12 deficiency: the role of H2 receptor antagonists and proton pump inhibitors.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus; Famotidine; Gastritis; Histamine H2 Antagonists; Humans; | 2007 |
[Properties of a new drug famocid: indications and contraindications of its use?].
Topics: Contraindications; Duodenitis; Famotidine; Gastritis; Humans; Kidney; Liver; Peptic Ulcer | 1995 |
[Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis].
Topics: Anti-Ulcer Agents; Cisapride; Drug Therapy, Combination; Famotidine; Female; Gastritis; Gastrointest | 1994 |
Reversion by histamine H2-receptor antagonists of plasma membrane alterations in ethanol-induced gastritis.
Topics: Animals; Cell Membrane; Cholesterol; Cimetidine; Ethanol; Famotidine; Gastric Mucosa; Gastritis; His | 1996 |
[Effect of a novel antiulcer drug, lafutidine, on experimental chronic gastritis in rats].
Topics: Acetamides; Ammonia; Animals; Anti-Ulcer Agents; Cell Count; Chronic Disease; Cimetidine; Famotidine | 1997 |
[Bicarbonate deficiency and duodenal peptic ulcer].
Topics: Acid-Base Equilibrium; Adult; Bicarbonates; Chronic Disease; Duodenal Ulcer; Famotidine; Female; Gas | 1998 |
[A case of the phlegmonous gastritis successfully treated by conservative therapy].
Topics: Aged; Anti-Ulcer Agents; Cellulitis; Famotidine; Female; Gastritis; Gastroscopy; Humans; Staphylococ | 1998 |
Use of a [13C]urea breath test for detection of gastric infection with Helicobacter spp in dogs.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Carbon Isotope | 1998 |
The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chile; Developing Countries; Drug Therapy, | 2000 |
Follow-up of endoscopic gastritis after healing with sucralfate or an H2-receptor antagonist.
Topics: Famotidine; Female; Follow-Up Studies; Gastritis; Gastroscopy; Humans; Male; Recurrence; Sucralfate; | 1992 |
Acute gastroduodenal mucosal injury after cisplatin plus etoposide chemotherapy. Clinical and endoscopic study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Endoscopy; Etoposide; Famotidine; | 1991 |
Frequent non-response to histamine H2-receptor antagonists in cirrhotics.
Topics: Anti-Ulcer Agents; Cimetidine; Esophagitis, Peptic; Famotidine; Female; Gastric Acidity Determinatio | 1989 |